Nausea is the most common adverse effect , occurring in approximately 40-50% of patients taking GLP-1 receptor agonists, though rates vary by product and dose according to clinical trials (STEP trials for semaglutide
The baseline characteristics were 42% with hypertension, 19% with type 2 diabetes, 43% with dyslipidemia, 28% with a BMI greater than 40 kg/m2 and 4% with CV disease
Bringing Hair Confidence Back Hair loss, especially when triggered by something like a medication change or rapid weight loss, can be emotionally challenging
Even though Smartlipo requires a larger upfront investment than medications, liposuction is a permanent solution
GLP-1 drugs may also accelerate the shift away from packaged food products toward fresh and frozen, the report said
The mitochondria are the powerhouses of the cell